PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 43 filers reported holding PROQR THRAPEUTICS N V in Q3 2020. The put-call ratio across all filers is 6.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $127,000 | -96.7% | 15,896 | -96.5% | 0.03% | -93.7% |
| Q3 2021 | $3,793,000 | +24.2% | 453,182 | 0.0% | 0.41% | +50.0% |
| Q2 2021 | $3,054,000 | +1.9% | 453,182 | 0.0% | 0.27% | +19.1% |
| Q1 2021 | $2,996,000 | +57.4% | 453,182 | 0.0% | 0.23% | +56.5% |
| Q4 2020 | $1,903,000 | -30.9% | 453,182 | 0.0% | 0.15% | -52.6% |
| Q2 2020 | $2,755,000 | +12.1% | 453,182 | +1.2% | 0.31% | -34.0% |
| Q1 2020 | $2,458,000 | -44.7% | 447,657 | -0.3% | 0.47% | -70.1% |
| Q4 2019 | $4,448,000 | +65.8% | 448,880 | -3.6% | 1.57% | -6.5% |
| Q3 2019 | $2,682,000 | -36.7% | 465,580 | 0.0% | 1.68% | +10.9% |
| Q2 2019 | $4,237,000 | +379.8% | 465,580 | +631.1% | 1.52% | +791.8% |
| Q1 2019 | $883,000 | – | 63,680 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 2,401,570 | $14,602,000 | 2.94% |
| DAFNA Capital Management LLC | 1,237,400 | $7,523,000 | 2.17% |
| RTW INVESTMENTS, LP | 4,902,785 | $29,809,000 | 0.84% |
| Kerrisdale Advisers, LLC | 453,182 | $2,755,000 | 0.31% |
| COWEN AND COMPANY, LLC | 300,042 | $1,824,000 | 0.30% |
| Artal Group S.A. | 1,259,177 | $7,656,000 | 0.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 4,550,062 | $27,664,000 | 0.07% |
| ALTRINSIC GLOBAL ADVISORS LLC | 221,360 | $1,346,000 | 0.06% |
| FRANKLIN STREET ADVISORS INC /NC | 60,000 | $365,000 | 0.04% |
| JENNISON ASSOCIATES LLC | 2,625,514 | $15,963,000 | 0.01% |